<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37040053</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Tuberculosis remains a leading contributor to morbidity due to serious infections in Indian patients of SLE.</ArticleTitle><Pagination><StartPage>2079</StartPage><EndPage>2090</EndPage><MedlinePgn>2079-2090</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06592-x</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Infections are a major cause of morbidity and mortality in systemic lupus erythematosus (SLE). We assessed the incidence and risk factors for major infections in SLE in India.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective review of a cohort of 1354 patients of adult SLE (ACR 1997 criteria) seen between 2000 and 2021 at a single center was conducted. Serious infections (need for hospitalisation, prolonged intravenous antibiotics, disability, or death) were recorded. Cox regression was used to determine factors associated with serious infection and the effects of serious infection on survival and damage.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 1354 patients (1258 females, mean age of 30.3&#xa0;years, follow-up of 7127.89 person-years), there were 439 serious infections in 339 patients (61.6 per 1000 person-years follow-up). Bacterial infections (N&#x2009;=&#x2009;226) were the most common infection followed by mycobacterial infections (n&#x2009;=&#x2009;81), viral (n&#x2009;=&#x2009;35), and then invasive fungal infections (N&#x2009;=&#x2009;13). Mycobacterium tuberculosis was the single most common microbiologically confirmed organism with incidence of 1136.4/100,000 person-years with 72.8% of them being extrapulmonary. Infection free survival at 1&#xa0;year and 5&#xa0;years was 82.9% and 73.8%. There were 119 deaths with infection attributable mortality in 65 (54.6%). On multivariable Cox regression analysis, higher baseline activity (HR 1.02, 1.01-1.05), gastrointestinal involvement (HR 2.75, 1.65-4.69), current steroid dose (HR 1.65, 1.55-1.76), and average cumulative steroid dose per year (HR 1.007, 1.005-1.009) were associated with serious infection and higher albumin (HR 0.65, 0.56-0.76) was protective. Serious infections led to greater damage accrual (median SLICC damage index of 1 vs. 0) and mortality (HR was 18.2, 32.7 and 81.6 for the first, second, and third infections).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Serious infections remain a major cause of mortality and damage accrual in SLE and higher disease activity, gastrointestinal involvement, hypoalbuminemia, current steroid dose, and cumulative steroid dose are the risk factors for it.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chatterjee</LastName><ForeName>Rudrarpan</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3558-0178</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology &amp; Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pattanaik</LastName><ForeName>Sarit Sekhar</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0001-5878-0837</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology &amp; Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Misra</LastName><ForeName>Durga P</ForeName><Initials>DP</Initials><Identifier Source="ORCID">0000-0002-5035-7396</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology &amp; Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Vikas</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-4508-1233</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology &amp; Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawrence</LastName><ForeName>Able</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3439-8048</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology &amp; Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Misra</LastName><ForeName>Ramnath</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7921-4199</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology &amp; Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>Amita</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2187-5186</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology &amp; Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. aa.amita@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014376" MajorTopicYN="Y">Tuberculosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="Y">Bacterial Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Staphylococcus aureus</Keyword><Keyword MajorTopicYN="N">Streptococcus pneumoniae</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">Tuberculosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>11</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37040053</ArticleId><ArticleId IdType="pmc">PMC10088612</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06592-x</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06592-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med. 1976;60(2):221&#x2013;225. doi: 10.1016/0002-9343(76)90431-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(76)90431-9</ArticleId><ArticleId IdType="pubmed">1251849</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas D, Mathias A, Dayal R, Aggarwal A, Misra R, Naik S. Presence of antibodies to SSB/La is associated with decreased phagocytic efficiency of neutrophils in patients with systemic lupus erythematosus. Clin Rheumatol. 2008;27(6):717&#x2013;722. doi: 10.1007/s10067-007-0776-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-007-0776-x</ArticleId><ArticleId IdType="pubmed">17985193</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuchacovich R, Gedalia A. Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus. Rheum Dis Clin North Am. 2009;35(1):75&#x2013;93. doi: 10.1016/j.rdc.2009.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2009.03.003</ArticleId><ArticleId IdType="pubmed">19480998</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfa;a-Figueroa I, N&#xf3;voa J, Garc&#xed;a-Laorden MI, Erausquin C, Garc&#xed;a-Bello M, de Castro FR, Herrera-Ramos E, Ojeda S, Quevedo JC, Francisco F, Naranjo A, Rodr&#xed;guez-Lozano C, Rodr&#xed;guez-Gallego C. Clinical and immunogenetic factors associated with pneumonia in patients with systemic lupus erythematosus: a case-control study. J Rheumatol. 2014;41(9):1801&#x2013;1807. doi: 10.3899/jrheum.131470.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.131470</ArticleId><ArticleId IdType="pubmed">25086072</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldblatt F, Chambers S, Rahman A, Isenberg DA. Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus. 2009;18(8):682&#x2013;689. doi: 10.1177/0961203308101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203308101019</ArticleId><ArticleId IdType="pubmed">19502263</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mej&#xed;a JC, Aydintug AO, Chwalinska-Sadowska H, de Ram&#xf3;n E, Fern&#xe1;ndez-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, European Working Party on Systemic Lupus Erythematosus (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 82(5):299&#x2013;308. 10.1097/01.md.0000091181.93122.55</Citation><ArticleIdList><ArticleId IdType="pubmed">14530779</ArticleId></ArticleIdList></Reference><Reference><Citation>No&#xeb;l V, Lortholary O, Casassus P, Cohen P, G&#xe9;n&#xe9;reau T, Andr&#xe9; MH, Mouthon L, Guillevin L. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis. 2001;60(12):1141&#x2013;1144. doi: 10.1136/ard.60.12.1141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.60.12.1141</ArticleId><ArticleId IdType="pmc">PMC1753456</ArticleId><ArticleId IdType="pubmed">11709457</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, Tarp U, Poulsen LH, van Overeem Hansen G, Skaarup B, Hansen TM, P&#xf8;denphant J, Halberg P. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol. 1998;17(6):478&#x2013;484. doi: 10.1007/BF01451283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01451283</ArticleId><ArticleId IdType="pubmed">9890675</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao K, Xie H, Li L, Esdaile JM, Avi&#xf1;a-Zubieta JA. Increased risk of severe infections and mortality in patients with newly diagnosed systemic lupus erythematosus: a population-based study. Rheumatology (Oxford) 2021;60(11):5300&#x2013;5309. doi: 10.1093/rheumatology/keab219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab219</ArticleId><ArticleId IdType="pubmed">33751035</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zhou Y, Yu L, Wu W, Zhao L, Geng S, Sun F, Zhang D, Shen N, Chen Y, Ye S. Major infections in newly diagnosed systemic lupus erythematosus: an inception cohort study. Lupus Sci Med. 2022;9(1):e000725. doi: 10.1136/lupus-2022-000725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2022-000725</ArticleId><ArticleId IdType="pmc">PMC9438011</ArticleId><ArticleId IdType="pubmed">36041813</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal A, Phatak S, Srivastava P, Lawrence A, Agarwal V, Misra R. Outcomes in juvenile onset lupus: single center cohort from a developing country. Lupus. 2018;27(11):1867&#x2013;1875. doi: 10.1177/0961203318791046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318791046</ArticleId><ArticleId IdType="pubmed">30071768</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattanaik SS, Muhammed H, Chatterjee R, Naveen R, Lawrence A, Agarwal V, Misra DP, Gupta L, Misra R, Aggarwal A. In-hospital mortality and its predictors in a cohort of SLE from Northern India. Lupus. 2020;29(14):1971&#x2013;1977. doi: 10.1177/0961203320961474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320961474</ArticleId><ArticleId IdType="pubmed">32998621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman DD, Hussain F, Iba&#xf1;ez D, Urowitz MB. The nature and outcome of infection in systemic lupus erythematosus. Lupus. 2002;11(4):234&#x2013;239. doi: 10.1191/0961203302lu170oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203302lu170oa</ArticleId><ArticleId IdType="pubmed">12043887</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Xie J, Chen H, Yang Y, Zhan Z, Liang L, Yang X. Infection in southern Chinese patients with systemic lupus erythematosus: spectrum, drug resistance, outcomes, and risk factors. J Rheumatol. 2016;43(9):1650&#x2013;1656. doi: 10.3899/jrheum.151523.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.151523</ArticleId><ArticleId IdType="pubmed">27307524</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfa;a-Figueroa &#xcd;, L&#xf3;pez-Longo J, Galindo-Izquierdo M, Calvo-Al&#xe9;n J, Del Campo V, Oliv&#xe9;-Marqu&#xe9;s A, P&#xe9;rez-Vicente S, Fern&#xe1;ndez-Nebro A, Andr&#xe9;s M, Erausquin C, Tomero E, Horcada L, Uriarte E, Freire M, Montilla C, S&#xe1;nchez-Atrio A, Santos G, Boteanu A, D&#xed;ez-&#xc1;lvarez E, Pego-Reigosa JM. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2017;47(1):38&#x2013;45. doi: 10.1016/j.semarthrit.2017.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2017.01.010</ArticleId><ArticleId IdType="pubmed">28259425</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubula T, Mody GM. Spectrum of infections and outcome among hospitalized South Africans with systemic lupus erythematosus. Clin Rheumatol. 2015;34(3):479&#x2013;488. doi: 10.1007/s10067-014-2847-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-014-2847-0</ArticleId><ArticleId IdType="pubmed">25535200</ArticleId></ArticleIdList></Reference><Reference><Citation>Oku K, Hamijoyo L, Kasitanon N, Li MT, Navarra S, Morand E, Tanaka Y, Mok CC. Prevention of infective complications in systemic lupus erythematosus: a systematic literature review for the APLAR consensus statements. Int J Rheum Dis. 2021;24(7):880&#x2013;895. doi: 10.1111/1756-185X.14125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.14125</ArticleId><ArticleId IdType="pubmed">33999518</ArticleId></ArticleIdList></Reference><Reference><Citation>Amorim LDAF, Cai J. Modelling recurrent events: A tutorial for analysis in epidemiology. Int J Epidemiol. 2015;44(1):324&#x2013;333. doi: 10.1093/ije/dyu222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu222</ArticleId><ArticleId IdType="pmc">PMC4339761</ArticleId><ArticleId IdType="pubmed">25501468</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PK, Keiding N. Multi-state models for event history analysis. Stat Methods Med Res. 2002;11(2):91&#x2013;115. doi: 10.1191/0962280202SM276ra.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0962280202SM276ra</ArticleId><ArticleId IdType="pubmed">12040698</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko T, Koelmeyer R, Li N, Yap K, Yeo AL, Kent J, Pellicano R, Golder V, Kitching AR, Morand E, Hoi A. Predictors of infection requiring hospitalization in patients with systemic lupus erythematosus: a time-to-event analysis. Sem Arthritis Rheum. 2022;57:152099. doi: 10.1016/j.semarthrit.2022.152099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2022.152099</ArticleId><ArticleId IdType="pubmed">36155969</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirobhushanam S, Parsa N, Reed TJ, Berthier CC, Sarkar MK, Hile GA, Tsoi LC, Banfield J, Dobry C, Horswill AR, Gudjonsson JE, Kahlenberg JM. Staphylococcus aureus colonization is increased on lupus skin lesions and is promoted by IFN-mediated barrier disruption. J Invest Dermatol. 2020;140(5):1066&#x2013;1074.e4. doi: 10.1016/j.jid.2019.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2019.11.016</ArticleId><ArticleId IdType="pmc">PMC7183889</ArticleId><ArticleId IdType="pubmed">31877319</ArticleId></ArticleIdList></Reference><Reference><Citation>Terui H, Yamasaki K, Wada-Irimada M, Onodera-Amagai M, Hatchome N, Mizuashi M, Yamashita R, Kawabe T, Ishii N, Abe T, Asano Y, Aiba S. Staphylococcus aureus skin colonization promotes SLE-like autoimmune inflammation via neutrophil activation and the IL-23/IL-17 axis. Sci Immunol. 2022;7(76):eabm9811. doi: 10.1126/sciimmunol.abm9811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abm9811</ArticleId><ArticleId IdType="pubmed">36306369</ArticleId></ArticleIdList></Reference><Reference><Citation>Luijten RKMAC, Cuppen BVJ, Bijlsma JWJ, Derksen RHWM. Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections. Lupus. 2014;23(14):1512&#x2013;1516. doi: 10.1177/0961203314543918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314543918</ArticleId><ArticleId IdType="pubmed">25078055</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurder J, Goulenok T, Jouenne R, Dossier A, Van Gysel D, Papo T, Sacre K. Pneumococcal infection in patients with systemic lupus erythematosus. Joint Bone Spine. 2018;85(3):333&#x2013;336. doi: 10.1016/j.jbspin.2017.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2017.05.012</ArticleId><ArticleId IdType="pubmed">28529115</ArticleId></ArticleIdList></Reference><Reference><Citation>Merayo-Chalico J, G&#xf3;mez-Mart&#xed;n D, Pi&#xf1;eir&#xfa;a-Men&#xe9;ndez A, Santana-De Anda K, Alcocer-Varela J. Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study. QJM: Mon J Assoc Physicians. 2013;106(5):451&#x2013;457. doi: 10.1093/qjmed/hct046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hct046</ArticleId><ArticleId IdType="pubmed">23458779</ArticleId></ArticleIdList></Reference><Reference><Citation>Global tuberculosis report 2021 (2021) Geneva: World Health Organization. https://www.who.int/publications/i/item/9789240037021. Accessed 29 Jan&#xa0;2023</Citation></Reference><Reference><Citation>Victorio-Navarra ST, Dy EE, Arroyo CG, Torralba TP. Tuberculosis among Filipino patients with systemic lupus erythematosus. Semin Arthritis Rheum. 1996;26(3):628&#x2013;634. doi: 10.1016/s0049-0172(96)80013-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0049-0172(96)80013-8</ArticleId><ArticleId IdType="pubmed">8989807</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng PH, Tan TH. Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis. 1982;41(1):11&#x2013;14. doi: 10.1136/ard.41.1.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.41.1.11</ArticleId><ArticleId IdType="pmc">PMC1000855</ArticleId><ArticleId IdType="pubmed">7065724</ArticleId></ArticleIdList></Reference><Reference><Citation>Shyam C, Malaviya AN. Infection-related morbidity in systemic lupus erythematosus: a clinico-epidemiological study from northern India. Rheumatol Int. 1996;16(1):1&#x2013;3. doi: 10.1007/BF01419946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01419946</ArticleId><ArticleId IdType="pubmed">8783414</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam L-S, Li EK, Wong S-M, Szeto C-C. Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong. Scand J Rheumatol. 2002;31(5):296&#x2013;300. doi: 10.1080/030097402760375205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/030097402760375205</ArticleId><ArticleId IdType="pubmed">12455821</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayarlioglu M, Inanc M, Kamali S, Cefle A, Karaman O, Gul A, Ocal L, Aral O, Konice M. Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization. Lupus. 2004;13(4):274&#x2013;278. doi: 10.1191/0961203303lu529xx.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203303lu529xx</ArticleId><ArticleId IdType="pubmed">15176665</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou C-L, Tsai Y-C, Chen L-C, Huang J-L. Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared. Clin Rheumatol. 2008;27(5):557&#x2013;563. doi: 10.1007/s10067-007-0741-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-007-0741-8</ArticleId><ArticleId IdType="pubmed">17940720</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Thumboo J, Tan BH, Tan TT, Fong CHJ, Ng HS, Fong KY. The risk of tuberculosis in SLE patients from an Asian tertiary hospital. Rheumatol Int. 2017;37(6):1027&#x2013;1033. doi: 10.1007/s00296-017-3696-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-017-3696-3</ArticleId><ArticleId IdType="pubmed">28286903</ArticleId></ArticleIdList></Reference><Reference><Citation>Lao M, Chen D, Wu X, Chen H, Qiu Q, Yang X, Zhan Z. Active tuberculosis in patients with systemic lupus erythematosus from Southern China: a retrospective study. Clin Rheumatol. 2019;38(2):535&#x2013;543. doi: 10.1007/s10067-018-4303-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-018-4303-z</ArticleId><ArticleId IdType="pubmed">30244432</ArticleId></ArticleIdList></Reference><Reference><Citation>Long W, Cai F, Wang X, Zheng N, Wu R. High risk of activation of latent tuberculosis infection in rheumatic disease patients. Infect Dis (London, England) 2020;52(2):80&#x2013;86. doi: 10.1080/23744235.2019.1682187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2019.1682187</ArticleId><ArticleId IdType="pubmed">31656117</ArticleId></ArticleIdList></Reference><Reference><Citation>Beydon M, Nicaise-Roland P, Mageau A, Farkh C, Daugas E, Descamps V, Dieude P, Dossier A, Goulenok T, Farhi F, Mutuon P, Timsit J-F, Papo T, Sacre K. Autoantibodies against IFN&#x3b1; in patients with systemic lupus erythematosus and susceptibility for infection: a retrospective case-control study. Sci Rep. 2022;12(1):11244. doi: 10.1038/s41598-022-15508-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15508-9</ArticleId><ArticleId IdType="pmc">PMC9253327</ArticleId><ArticleId IdType="pubmed">35788140</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaitonde S. Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment. Ann Rheum Dis. 2002;61(3):251&#x2013;253. doi: 10.1136/ard.61.3.251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.61.3.251</ArticleId><ArticleId IdType="pmc">PMC1754016</ArticleId><ArticleId IdType="pubmed">11830432</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, Lin B, Wang L, Wang D, Li G, Wang G. Preventive therapy for iatrogenic active tuberculosis in systemic lupus erythematosus patients. Zhonghua Yi Xue Za Zhi. 2014;94(45):3579&#x2013;3582.</Citation><ArticleIdList><ArticleId IdType="pubmed">25622838</ArticleId></ArticleIdList></Reference><Reference><Citation>Takizawa Y, Inokuma S, Tanaka Y, Saito K, Atsumi T, Hirakata M, Kameda H, Hirohata S, Kondo H, Kumagai S, Tanaka Y. Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population. Rheumatology (Oxford) 2008;47(9):1373&#x2013;1378. doi: 10.1093/rheumatology/ken231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ken231</ArticleId><ArticleId IdType="pubmed">18577548</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LR, Barber CE, Johnson AS, Barnabe C. Invasive fungal disease in systemic lupus erythematosus: a systematic review of disease characteristics, risk factors, and prognosis. Semin Arthritis Rheum. 2014;44(3):325&#x2013;330. doi: 10.1016/j.semarthrit.2014.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2014.06.001</ArticleId><ArticleId IdType="pubmed">25129259</ArticleId></ArticleIdList></Reference><Reference><Citation>Molooghi K, Sheybani F, Naderi H, Mirfeizi Z, Morovatdar N, Baradaran A. Central nervous system infections in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Lupus Sci Med. 2022;9(1):e000560. doi: 10.1136/lupus-2021-000560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2021-000560</ArticleId><ArticleId IdType="pmc">PMC8724813</ArticleId><ArticleId IdType="pubmed">34980679</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejera Segura B, Rua-Figueroa I, Pego-Reigosa JM, Del Campo V, Wincup C, Isenberg D, Rahman A. Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort. BMJ Open. 2019;9(6):e028697. doi: 10.1136/bmjopen-2018-028697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-028697</ArticleId><ArticleId IdType="pmc">PMC6589043</ArticleId><ArticleId IdType="pubmed">31203250</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Q, Xing X, Lu Z, Li X. Clinical characteristics and risk factors of infection in patients with systemic lupus erythematosus: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum. 2020;50(5):1022&#x2013;1039. doi: 10.1016/j.semarthrit.2020.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2020.06.004</ArticleId><ArticleId IdType="pubmed">32911280</ArticleId></ArticleIdList></Reference><Reference><Citation>Prata AR, Lu&#xed;s M, Assun&#xe7;&#xe3;o H, da Silva JAP, In&#xea;s LS. Antimalarial treatment and minimizing prednisolone are associated with lower risk of infection in SLE: a 24-month prospective cohort study. Clin Rheumatol. 2022;41(4):1069&#x2013;1078. doi: 10.1007/s10067-021-05988-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05988-x</ArticleId><ArticleId IdType="pubmed">34782940</ArticleId></ArticleIdList></Reference><Reference><Citation>Simard JF, Rossides M, Gunnarsson I, Svenungsson E, Arkema EV. Infection hospitalisation in systemic lupus in Sweden. Lupus Sci Med. 2021;8(1):e000510. doi: 10.1136/lupus-2021-000510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2021-000510</ArticleId><ArticleId IdType="pmc">PMC8444249</ArticleId><ArticleId IdType="pubmed">34526357</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K, Ishikawa Y, Kita Y, Yajima N, Inoue E, Sada K, Miyawaki Y, Yoshimi R, Shimojima Y, Ohno S, Kajiyama H, Ichinose K, Sato S, Fujiwara M. Association of low-dose glucocorticoid use and infection occurrence in systemic lupus erythematosus patients: a prospective cohort study. Arthritis Res Ther. 2022;24(1):179. doi: 10.1186/s13075-022-02869-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-022-02869-9</ArticleId><ArticleId IdType="pmc">PMC9330647</ArticleId><ArticleId IdType="pubmed">35902976</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh JA, Cleveland JD. Hospitalized infections in lupus: a nationwide study of types of infections, time trends, health care utilization, and in-hospital mortality. Arthritis Rheumatol (Hoboken, N.J.) 2021;73(4):617&#x2013;630. doi: 10.1002/art.41577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41577</ArticleId><ArticleId IdType="pubmed">33142044</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzo-Vizcaya A, Isenberg D. Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom. Lupus. 2021;30(5):702&#x2013;706. doi: 10.1177/0961203320988607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320988607</ArticleId><ArticleId IdType="pubmed">33472522</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutcliffe N, Clarke AE, Taylor R, Frost C, Isenberg DA. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2001;40(1):37&#x2013;47. doi: 10.1093/rheumatology/40.1.37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/40.1.37</ArticleId><ArticleId IdType="pubmed">11157140</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xf6;nsen A, Bengtsson AA, Hjalte F, Petersson IF, Willim M, Nived O. Total cost and cost predictors in systemic lupus erythematosus-8-years follow-up of a Swedish inception cohort. Lupus. 2015;24(12):1248&#x2013;1256. doi: 10.1177/0961203315584812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315584812</ArticleId><ArticleId IdType="pubmed">25957301</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Sawah S, Daly RP, Foster SA, Naegeli AN, Benjamin K, Doll H, Bond G, Moshkovich O, Alarc&#xf3;n GS. The caregiver burden in lupus: findings from UNVEIL, a national online lupus survey in the United States. Lupus. 2017;26(1):54&#x2013;61. doi: 10.1177/0961203316651743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316651743</ArticleId><ArticleId IdType="pubmed">27235701</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa-Reis P, Nativ S, Isgro J, Rodrigues T, Yildirim-Toruner C, Starr A, Saiman L, Imundo L, Eichenfield A. Major infections in a cohort of 120 patients with juvenile-onset systemic lupus erythematosus. Clin Immunol (Orlando, Fla.) 2013;149(3):442&#x2013;449. doi: 10.1016/j.clim.2013.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2013.08.009</ArticleId><ArticleId IdType="pubmed">24211846</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Torres V, Mart&#xed;nez-Urbistondo M, Guti&#xe9;rrez-Rojas A, Castej&#xf3;n R, S&#xe1;nchez E, Calder&#xf3;n-Parra J, Dur&#xe1;n-del Campo P, Tutor P, Mellor-Pita S, V&#xe1;zquez-Comendador J, Vargas-N&#xfa;&#xf1;ez JA, Ruiz-Irastorza G. Impact of severe infections in SLE: an observational study from the Spanish national registry. Lupus Sci Med. 2022;9(1):e000711. doi: 10.1136/lupus-2022-000711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2022-000711</ArticleId><ArticleId IdType="pmc">PMC9608526</ArticleId><ArticleId IdType="pubmed">36283745</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson P, Brennan A, Birch H, Fang H, Petri M. An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins lupus cohort. Rheumatology (Oxford) 2015;54(4):623&#x2013;632. doi: 10.1093/rheumatology/keu375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu375</ArticleId><ArticleId IdType="pubmed">25234659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedves M, K&#xf3;sa F, Kunovszki P, Tak&#xe1;cs P, Szab&#xf3; MZ, Karyekar C, Lofland JH, Nagy G. Large-scale mortality gap between SLE and control population is associated with increased infection-related mortality in lupus. Rheumatology (Oxford) 2020;59(11):3443&#x2013;3451. doi: 10.1093/rheumatology/keaa188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa188</ArticleId><ArticleId IdType="pmc">PMC7590419</ArticleId><ArticleId IdType="pubmed">32357240</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YH, Choi SJ, Ji JD, Song GG. Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus. 2016;25(7):727&#x2013;734. doi: 10.1177/0961203315627202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315627202</ArticleId><ArticleId IdType="pubmed">26811368</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>